| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |